Login to Your Account

Cardiome Corrals Correvio, Gains Cash for Brinavess

By Marie Powers
Staff Writer

Tuesday, November 19, 2013
Cardiome Pharma Corp. and privately held specialty pharma Correvio LLC consummated a marriage of convenience that may create a company stronger than the sum of the two partners. Correvio, based in Geneva, markets the single product Aggrastat (tirofiban HCL) to cardiologists in more than 60 countries, generating annual revenues of approximately $30 million.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription